Global Antibiotic Resistance Market Trends 2024, Forecast To 2033
8 Mar, 2024
The antibiotic resistance market has also experienced significant growth, rising from $11.43 billion in 2023 to $12.13 billion in 2024 at a CAGR of 6.1%. This growth is attributed to factors such as the misuse of antimicrobials and lack of new antibiotics. The market is expected to continue growing strongly, reaching $15.47 billion in 2028, with a CAGR of 6.3%. Factors contributing to this growth include globalization, poor infection control, and high population density. Major trends in the forecast period include technological innovations and global collaboration for surveillance.
Global Antibiotic Resistance Market Key Driver
The prevalence of drug-resistant infections, leading to thousands of deaths each year in the European Union according to the European Centre for Disease Prevention and Control, is expected to drive the growth of the antibiotic resistance market. Antimicrobial resistance drugs are crucial in treating drug-resistant infections, addressing the challenges posed by resistant bacteria and improving treatment outcomes.
Get A Free Sample Of The Global Antibiotic Resistance Market ReportGlobal Antibiotic Resistance Market Segments
The antibiotic resistance market covered in this report is segmented –
1) Drug Class:Beta Lactum Antibiotic, Cephalosporins, Quinolones Antibiotics, Macrolide Antibiotics, Tetracyclines, Oxazolidinones, Other Drug Classes
2) Pathogen:Staphylococcus aureus, Staphylococcus pneumonia, Neisseria gonorrhoeae, Enterococcus Faecium, Escherichia coli, Klebsiella pneumonia, Shigella, Clostridium difficile, Other pathogens
3) Disease Type:Urinary tract infection, Intra-abdominal infection, Blood stream infections, Clostridium difficile infections, Other Disease Types
4) Mechanism of Action:Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Other Mechanism Of Actions
5) End Users:Hospitals, Homecare, Specialty clinics, Other End-users
By Geography: The countries covered in the antibiotic resistance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the antibiotic resistance market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibiotic resistance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major Antibiotic Resistance Industry Players
Pfizer Inc.; Johnson and Johnson; F. Hoffmann-La Roche Ltd; AbbVie Inc.; Novartis AG; Merck and Co. Inc.; Bristol-Myers Squibb; Sanofi S.A.; Thermo Fisher Scientific Inc; AstraZeneca; GlaxoSmithKline Plc; Eli Lilly and Company; Boehringer Ingelheim International GmbH; Astellas Pharma; Daiichi Sankyo; Chugai Pharmaceutical Co. Ltd.; Teva Pharmaceutical Industries Ltd.; Bio-Rad Laboratories Inc; Eppendorf Corporation; Takara Bio Inc; Wockhardt Ltd.; Paratek Pharmaceuticals Inc.; Basilea Pharmaceutica Ltd.; Theravance Biopharma Inc.; Nabriva Therapeutics Plc; Seres Therapeutics Inc; Armata Pharmaceuticals Inc.
Get The Full Global Antibiotic Resistance Market Report
Antibiotic Resistance Market Overview
Antimicrobial resistance is a condition that occurs when microorganisms such as bacteria and fungi gain the capacity to resist medications that are meant to kill them. Resistance to infections is challenging to treat, leading to the death of an infected individual in the worst cases.